Bionet (1784) - Total Liabilities

Latest as of December 2025: NT$822.58 Million TWD ≈ $25.92 Million USD

Based on the latest financial reports, Bionet (1784) has total liabilities worth NT$822.58 Million TWD (≈ $25.92 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bionet - Total Liabilities Trend (2017–2025)

This chart illustrates how Bionet's total liabilities have evolved over time, based on quarterly financial data. Check 1784 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Bionet Competitors by Total Liabilities

The table below lists competitors of Bionet ranked by their total liabilities.

Company	Country	Total Liabilities
Logistic Properties of the Americas NYSE MKT:LPA	USA	$376.20 Million
Hurriyet Gazetecilik ve Matbaacilik AS IS:HURGZ	Turkey	TL2.59 Billion
Petrolimex Insurance Corp VN:PGI	Vietnam	₫7.67 Trillion
Loop Telecommunication International Inc TW:3025	Taiwan	NT$399.52 Million
Kron Telekomunikasyon Hizmetleri AS IS:KRONT	Turkey	TL402.17 Million
Champion Building Materials Co Ltd TW:1806	Taiwan	NT$2.91 Billion
M & A EQUITY HOLDINGS BERHAD KLSE:7082	Malaysia	RM85.15 Million
New Fortress Energy LLC NASDAQ:NFE	USA	$10.25 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Bionet's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bionet asset portfolio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.62	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bionet's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bionet (2017–2025)

The table below shows the annual total liabilities of Bionet from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$822.58 Million ≈ $25.92 Million	+8.18%
2024-12-31	NT$760.40 Million ≈ $23.96 Million	+21.38%
2023-12-31	NT$626.47 Million ≈ $19.74 Million	+21.89%
2022-12-31	NT$513.97 Million ≈ $16.19 Million	+9.78%
2021-12-31	NT$468.19 Million ≈ $14.75 Million	+5.11%
2020-12-31	NT$445.44 Million ≈ $14.03 Million	-1.86%
2019-12-31	NT$453.87 Million ≈ $14.30 Million	+2.43%
2018-12-31	NT$443.09 Million ≈ $13.96 Million	-2.26%
2017-12-31	NT$453.33 Million ≈ $14.28 Million	--

About Bionet

TWO:1784 Taiwan Diagnostics & Research

Market Cap

$97.95 Million

NT$3.11 Billion TWD

Market Cap Rank

#19288 Global

#1083 in Taiwan

Share Price

NT$61.80

Change (1 day)

+2.66%

52-Week Range

NT$56.10 - NT$115.50

All Time High

NT$161.50